The Breast reconstruction & augmentation market is expected to reach USD 463 million by 2030 at a CAGR of 2.8 % during the forecast period of 2022 to 2030. Breast & augmentation, commonly known as breast enlargement, is a popular surgical procedure that improves the size and shape of the breast. According to the annual plastic surgery procedural statistics, there were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in 2017, a 2% increase over 2016. The American Society of Plastic Surgeons (ASPS) stated that breast augmentation is one of the top five cosmetic procedures conducted in the US. There were 300,378 total breast augmentations in the US in 2017. The statistics by the American Society of Plastic Surgeons (ASPS), stated the average cost of a breast augmentation surgery was USD 3,708 in 2014. Factors such as increased focus on physical appearance and increase in availability of favorable cohesive silicone breast implants are driving the growth of the market.
The primary customer base for breast augmentation is women belonging to middle- and high-income families. The World Bank estimates that the global annual disposable income per capita for women is expected to increase at a CAGR of approximately 6% over the forecast period, driving the expansion of the market globally. In addition, the rise in the prevalence of breast cancer and the availability of wide range options for breast implants fuel the market growth. As per the data released by the World Health Organization (WHO), in 2012, 1.7 million women were diagnosed with breast cancer, leading to approximately 522,000 deaths during the same year.
The breast reconstruction surgery is the creation of new breast shape, or mound, using surgery. The American Cancer Society estimated that 252,710 new cases of invasive breast cancer were diagnosed in the US in 2017. According to the ASPS, breast reconstruction & augmentation accounted for 109,256 procedures in 2016 or 1.9% of all the reconstructive procedures.
The Breast reconstruction & augmentation market is segmented based on type, product type, end user and region.
On the basis type, the Breast reconstruction & augmentation market is segmented into Implant reconstruction, Autologous or "flap" reconstruction. Further, on the basis of product type the market is segmented into silicone, saline. end user is segmented into hospitals & clinics, ambulatory surgical centers, cosmetic surgery centers and others.
Regional Market Summary
In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.
The Americas accounts for the largest regional Breast reconstruction & augmentationmarket owing to the increasing number of cosmetic procedures performed annually, a rising number of clinics, and the wide availability of skilled specialists. A number of leading and new players are focusing on research and development to incorporate various new technologies, to overcome issues associated with existing implants. For instance, in September 2016, Allergen received the US FDA approval to market NATRELLE INSPIRA, a cohesive breast implant as its newest category into gummy implants to increase breast fullness.
Europe is anticipated to hold the second largest market for breast implants during the forecast period. According to Statista, the number of silicone type breast augmentation surgeries performed in Italy in 2017 was 48,240.
Moreover, Asia-Pacific is anticipated to exhibit high growth, owing to the reduced cost of implantation procedures, leading to rise of medical tourism in Asian countries such as India, China, and other South-East Asian economies. For instance, according to IndiCure Health Tours Pvt. Ltd, an Indian Medical Tour consulting company, the cost of breast implant surgeries performed in India is almost one-third of the cost for the procedures in the US.
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Breast reconstruction & augmentation market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.
Market Segmentation and Key Market Players
Breast reconstruction & augmentation Market, by Type
Breast reconstruction & augmentation Market, by Product type
Breast reconstruction & augmentation Market, by End User
Breast reconstruction & augmentation Market, by Key Players
|Market Size||USD 463 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By type, product type, end user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Allergan Inc, Sientra Inc, GC Aesthetics, Mentor Worldwide LLC (Part of Johnson & Johnson), Establishment Labs, Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG), Groupe Sebbin SAS, HansBiomed Co. Ltd, Laboratoires Arion, Cereplas, Ideal Implant Inc, Shanghai Kangning Medical Supplies Ltd, Guangzhou Wanhe Plastic Materials Co. Ltd|
|Key Market Opportunities||Increasing research & development investments by industry players|
|Key Market Drivers||
Global Breast Reconstruction & Augmentation Market could launch initiatives with a target to reach 2.8% CAGR during the forecast period covering 2022 to 2030.
High income and growing impact of the entertainment industries are expected to trigger growth for the Breast Reconstruction & Augmentation Market.
Which region has the maximum Breast Reconstruction & Augmentation Market share?
The Asia Pacific is the fastest-growing region of the global Breast Reconstruction & Augmentation Market.
What are the product types discussed in the Breast Reconstruction & Augmentation Market?